Identity and percentage holding of significant shareholders
Substantial holdings | Shares held | % |
---|---|---|
Directors and related shareholders | ||
Russ Shaw | 2,700,000 | 0.43% |
Ian Gilham | 2,505,961 | 0.4% |
Gino Miele | 2,202,187 | 0.35% |
Tom Lindsay | 1,151,605 | 0.18% |
Chris Yates | 267,554 | 0.04% |
Total Directors' holdings | 8,827,307 | 1.41% |
Total shares in issue | 624,895,408 | 100.00% |
Shareholder information
genedrive shares are quoted and traded on the AIM market of the London Stock Exchange.
Authorised Share Capital: No authorised maximum number of shares are required. There are no shares held in treasury and there are no restrictions on transfer.
Issued Share Capital: The total number of genedrive plc ordinary shares of 1.5p each in issue is 624,895,408.
Number of AIM securities not in public hands is 8,827,307 or 1.41%.
Text updated: 27/04/2025
Latest reports

05 December 2024
Annual Report and Accounts 2024
Investor News
Tuesday May 13, 2025
Genedrive test kits set for new NHS trial in Manchester
Tuesday August 06, 2024
genedrive shares down 10% after CEO departure
Friday August 02, 2024
Small-cap Movers: UK Oil & Gas lights up on innovative hydrogen pans